Keywords: antineutrophil antibodies; Crohn's disease; proteinuria; renal permselectivity; ulcerative colitis Background. A loss of intestinal glycosaminoglycans (GAGs) has been shown in inflammatory bowel diseases (IBD). Since GAGs are involved in the regulation of renal protein filtration and GAGs disruption is
Introduction
associated with anionic proteinuria, we examined whether changes in the selectivity of renal protein filtration occur in IBD.
Microalbuminuria has been reported in patients with inflammatory bowel diseases (IBD), suggesting that Methods. From 46 patients with IBD (17 with Crohn's disease (CD), and 29 with ulcerative colitis ( UC )) and subclinical renal changes may occur in these patients and that measurements of protein renal excretion may 21 healthy subjects, urine and serum samples were obtained. Albumin, total IgG and IgG 4 clearances be of use in detecting these changes [1] . The passage of proteins across the glomerular filtrawere measured using sensitive methods. Serum p-ANCA and TNF-a were tested. tion barrier is regulated by several factors. Small proteins, such as albumin, filter through approximately Results. Median IgG 4 clearance was 0.041 ml/ min/10−3 in patients with UC and 0.10 ml/ 5.5 nm glomerular pores, while immunoglobulins (Igs), because of their size (5.5 nm), can only escape across min/10−3 in CD patients, both significantly higher than in controls (0.03 ml/min/10−3) (P<0.03). IgG 4 the larger shunt pores of alternative filtration pathways (size-selectivity) [2] . Basement membrane pores are clearance was above the upper normal limit in 9/17 CD (53%) and in 10/29 UC (34.5%). Eighteen of 19 coated by fixed anionic charges, due to molecules of glycosaminoglycans (GAGs), capable of restricting the patients showing abnormal IgG 4 clearance were taking mesalazine. In patients on maintenance oral mesalaz-passage of negatively charged proteins (albumin, IgG 4 ) (charge selectivity) [3] . An 'anionic proteinuria' occurs ine, IgG 4 clearance was higher than that in patients off treatment (0.12 vs 0.03 ml/min/10−3, P=0.04 tions, the hypothesis was generated that changes in the Part of this study was presented at the 95th Annual Meeting of the selectivity of renal filtration of proteins occur in IBD. American Gastroenterological Association, 14-17 May 1995, San To test this hypothesis we examined the question of in the renal protein charge or size selectivity are p-ANCA involved. Using sensitive methods, we provide evidence ANCA were detected as previously reported [13] . Briefly, a that renal charge selectivity is impaired in 40% patients monolayer of 200 000 neutrophils, isolated from peripheral with IBD without overt proteinuria.
blood of healthy subjects, was air dried in each of 96 wells in a microtitre plate, fixed in 95% ethanol, air dried again, and blocked with 0.25% bovine serum albumin in phosphate-
Subjects and methods
buffered saline, pH 7.38. Sera were tested at a 1:100 dilution and bound antibody was detected using alkaline phosphatase conjugated anti-human IgG (Sigma, MO, USA). The test
Patients
was considered positive for antipolymorphonuclear cells when optical density (OD) readings were above the mean+2 Forty-six patients with IBD, 17 Crohn's disease (CD) and SD of negative control samples (OD values of negative 29 ulcerative colitis ( UC ), mean age 35±9, diagnosed control sera were 0.048±0.020). All samples positive by according the usual clinical, endoscopic and radiological ELISA were examined by indirect immunofluorescence as criteria were enrolled. In the CD group, the primary site of previously indicated [13] . Only samples showing a characterinvolvement was ileal in nine, ileocolonic in four, and colonic istic perinuclear pattern (p-ANCA) were considered as in four patients. In the UC group, disease extent was distal positive. Sera of 20 unaffected blood donors were used as in 10, left-sided in nine, and substantial in 10 patients. negative controls. Disease was active in 20/29 UC patients by the Truelove criteria [8] while the Crohn's Disease Activity Index (CDAI ) TNF-a assay [9] was >150 in 6/17 CD patients. Disease duration was 7.9±5.5 years in CD and 5.56±5.3 years in UC. Thirty-six TNF-a was measured in all serum samples using a commerpatients (24 UC and 12 CD) were on medical treatment (22 cially available ELISA assay (Medgenix Diagnostics SA, mesalazine and 14 mesalazine plus steroids). No patient had Fleurus, Belgium). Results were expressed as pg/ml and the been prescribed immunosuppressive or antibacterial drugs lowest detectable concentration was 15 pg/ml. over the last 12 months.
Ten patients (five UC and five CD) were not receiving any Statistical analysis medical treatment: four were newly diagnosed, while six patients in stable remission for more than 6 years had not The non-parametric two-tailed Wilcoxon's rank sum test and received any drug over the last 4 years. No IBD patient had Student's t-test were used as appropriate for the statistical clinical and/or laboratory signs of metabolic, renal, cardio-analysis of the data. The relation between protein clearances vascular, or neoplastic diseases. As control group, 21 healthy and clinical variables was also assessed by logistic regression subjects without any evidence of IBD (mean age 34±8 years) analysis. Prevalences of altered protein clearances in study were considered.
groups were analysed by x2-test and by Fisher's exact test when n<5. Relationship between serum TNF-a concentrations and IgG 4 clearances was performed by Pearson's test.
Blood and urine sampling
Timed overnight urine collections and serum samples were Results obtained from all subjects and stored at −20°C until tested.
For all urinary samples, proteinuria assays were performed In all but one IBD patient the albumin excretion rate within 2 weeks of collection.
was within the normal range (value <20 mg/min). Median albumin excretion rate was 3.4 mg/min (range Measurement of proteinuria 0.34-19.5) in UC, 3.8 mg/mm (range 0.35-33.7) in CD and 3.9 mg/min (range 1.02-12.07) in controls (P=0.6 In all patients and controls the urinary albumin excretion and 0.9 respectively). Albumin clearance was above rate ( UAER) and the clearances of albumin, total IgG, and the normal range (values >0.3 ml/min/10−3) in 3/46
IgG 4 were measured as previously reported [10] [11] [12] . All (6.5%) IBD patients and the median values did not urinary tests were performed on three consecutive overnight differ between UC, CD, and controls ( Table 1) . collections and the mean was used as representative of the Microalbuminuria was detected by the immunoturbidisubject's value. Protein concentrations were measured in metric assay in one CD patient showing an abnormal serum and urinary samples using a solid-phase RIA for albumin excretion rate. albumin and total IgG while an ELISA assay was used for As shown in Table 1 three patients (one UC and two CD) with increased IgG 4 clearance, an alteration in albumin clearance was also found. In these two CD patients, IgG clearance was also abnormal. No patient with normal IgG 4 clearance showed increased albumin or total IgG clearances. Eighteen UC patients (62%) and three CD patients (17.6%) were p-ANCA positive. No difference was observed in terms of IgG 4 clearances between patients positive (0.04 and 0.19 ml/min/10−3 in UC and CD respectively) and negative (0.045 and 0.09 ml/min/10−3 in UC and CD respectively) for p-ANCA. Moreover, no significant correlation was found between IgG 4 clearance and circulating levels of clearance and the various anatomical on mesalazine treatment than in untreated patients (P=0.04). groups of CD (ileum vs colon) or disease extent in UC (distal/left-sided vs pancolitis) (data not shown). treatment with mesalazine (0.12 ml/min/10−3) than Disease activity 1.214 0. 255-5.787 in untreated patients (0.03 ml/min/10−3) (P=0.04) ( Figure 1 and Table 2 ). Both CD and UC patients on treatment showed median IgG 4 clearance values (0.3 of 10 patients (five CD and five UC ) with altered IgG 4 and 0.05 ml/min/10−3 respectively) significantly higher clearance and keeping on continuous mesalazine treatthan those in controls (0.03 ml/min/10−3; P=0.007 ment, routine urinalysis was also performed and the and P=0.04 respectively). Furthermore, median IgG 4 levels of urinary urea, electrolytes, protein and creatinclearance was not significantly different between ine were estimated 2 years after assaying protein clearuntreated patients and controls.
ances. No alteration in renal laboratory parameters A repeat assay of the protein clearances was carried was observed in these 10 patients. Moreover, no clinical out in five patients selected among those with altered sign of renal dysfunction was documented in patients IgG 4
clearance and on continuous mesalazine treat-with altered IgG 4 clearance. ment. In all five patients, the repeat assay was consistent with the previous one. In addition, four of the 10 patients who were off treatment at entry (two CD and Discussion two UC ) and showing normal protein clearances were
In this study we report that 40% patients with IBD re-examined after being enrolled in a maintenance have abnormal renal IgG 4 clearance. In no patient programme with 2.4 g/day oral mesalazine. In two of with normal IgG 4 clearance were there alterations in these four patients (one CD and one UC ), IgG 4 the clearance of IgG 1 (i.e. cationic immunoglobulins), clearance increased above the upper normal limit suggesting that a charge selectivity impairment was (0.043 and 0.005 at entry, 3.39 and 0.5 ml/min/10−3 after 2 years mesalazine respectively). In a subgroup responsible for the observed change in protein clear-ance. Interestingly all patients, except one, showing
In conclusion, these data indicate that an abnormal renal protein charge permselectivity may be docualtered IgG 4 clearance were normoalbuminuric, clearly indicating that the loss of charge selectivity is limited mented in nearly 40% of IBD patients and that altered IgG 4 clearance represents a subclinical marker of renal to IgG 4 . These data support the view that in the earlier stages of altered renal charge permselectivity, the excess involvement. of IgG 4 passed through the glomerular membrane are
